Is it hyperthyroidism?: You can't always tell from the clinical picture

Postgraduate Medicine

Volumn 104, Issue 1, 1998, Pages 42-59

  Haddad, Ghada ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; CLOFIBRATE; DIAMORPHINE; FLUOROURACIL; IOPODATE SODIUM; METHADONE; PROPRANOLOL; PROPYLTHIOURACIL; RADIOACTIVE IODINE; TAMOXIFEN; TAMOXIFEN CITRATE; THIAMAZOLE;

AGRANULOCYTOSIS; CLINICAL FEATURE; CONFERENCE PAPER; DIAGNOSTIC APPROACH ROUTE; FEVER; GRAVES DISEASE; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTHYROIDISM; HYPERTHYROXINEMIA; LIVER DISEASE; PRACTICE GUIDELINE; RASH; THYROIDECTOMY; THYROIDITIS; THYROTOXICOSIS; TREATMENT INDICATION; WEIGHT REDUCTION;

EID: 0031828879     PISSN: 00325481     EISSN: None     Source Type: Journal    
DOI: 10.3810/pgm.1998.07.530     Document Type: Conference Paper

References (17)

1. Trzepacz PT, Klein I, Roberts M, et al. Graves' disease: an analysis of thyroid hormone levels and hyperthyroid signs and symptoms. Am J Med 1989;87(5):558-61
2. Sawin CT, Geller A, Wolf PA, et al. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med 1994;331(19):1249-52
3. Kung AW, Lorentz T, Tam SC. Thyroxine suppressive therapy decreases bone mineral density in post-menopausal women. Clin Endocrinol (Oxf) 1993;39(5):535-40
4. Marcocci C, Golia F, Bruno-Bossio G, et al. Carefully monitored levothyroxine suppressive therapy is not associated with bone loss in premenopausal women. J Clin Endocrinol Metab 1994; 78(4):818-23
5. Ruiz M, Rajatanavin R, Young RA, et al. Familial dysalbuminemic hyperthyroxinemia: a syndrome that can be confused with thyrotoxicosis. N Engl J Med 1982;306(11):635-9
6. Chopra IJ, Solomon DH, Huang TS. Serum thyrotropin in hospitalized psychiatric patients: evidence for hyperthyrottopinemia as measured by an ultrasensitive thyrotropin assay. Metabolism 1990; 39(5):538-43
7. Goodwin TM, Montoro M, Mestman JH, et al. The role of chorionic gonadotropin in transient hyperthyroidism of hyperemesis gravidarum. J Clin Endocrinol Metab 1992;75(5):1333-7
8. Burch HB, Wartofsky L. Graves' ophthalmopathy: current concepts regarding pathogenesis and management. Endocr Rev 1993; 14(6):747-93
9. Paschke R, Ludgate M. The thyrotropin receptor in thyroid diseases. N Engl J Med 1997;337(23):1675-81
10. Allannic H, Fauchet R, Orgiazzi J, et al. Antithyroid drugs and Graves' disease: a prospective randomized evaluation of the efficacy of treatment duration. J Clin Endocrinol Metab 1990;70(3):675-9
11. Hashizume K, Ichikawa K, Sakurai A, et al. Administration of thyroxine in treated Graves' disease: effects on the level of antibodies to thyroid-stimulating hormone receptors and on the risk of recurrence of hyperthyroidism. N Engl J Med 1991;324(14):947-53
12. Marchant B, Brownlie BE, Hart DM, et al. The placental transfer of propylthiouracil, methimazole and carbimazole. J Clin Endocrinol Metab 1977;45(6):1187-93
13. Mandel SJ, Brent GA, Larsen PR. Review of antithyroid drug use during pregnancy and report of a case of aplasia cutis. Thyroid 1994;4(1):129-33
14. Burrow GN. Thyroid function and hyperfunction during gestation. Endocr Rev 1993;14(2):194-202
15. Klein I, Becker DV, Levey GS. Treatment of hyperthyroid disease. Ann Intern Med 1994;121(4):281-8
16. Tallstedt L, Lundell G, Torring O, et al, for the Thyroid Study Group. Occurrence of ophthalmopathy after treatment for Graves' hyperthyroidism. N Engl J Med 1992;326(26):1733-8
17. Kung AW, Yau CC, Cheng A. The incidence of ophthalmopathy after radioiodine therapy for Graves' disease: prognostic factors and the role of methimazole. J Clin Endocrinol Metab 1994;79(2): 542-6